Literature DB >> 2149511

Plasma concentrations of atrial natriuretic peptide during physical exercise in patients with congestive heart failure.

M Haass1, R Dietz, J Purgaj, R E Lang, W Kübler.   

Abstract

Plasma concentrations of atrial natriuretic peptide (ANP) were measured in 25 patients with organic heart disease during physical exercise (baseline and maximum workload) in order to investigate if the responsiveness of stimulated release of ANP is still preserved in patients with heart failure and chronically elevated cardiac filling pressures. Since plasma concentrations of ANP are known to be positively correlated with mean right atrial pressures (RAP), the patients were divided into two groups according to their resting RAP; group I; those with normal RAP (less than or equal to 5 mmHg; n = 11); group II; those with elevated RAP (greater than 5 mmHg; n = 14). Under baseline conditions RAP (3.2 +/- 0.4 mmHg vs. 8.8 +/- 0.7 mmHg; p less than 0.01), pulmonary artery diastolic pressure (PADP; 9.5 +/- 0.9 mmHg vs. 17.9 +/- 1.8 pg/ml; p less than 0.01), and plasma ANP levels (128 +/- 19 pg/ml vs. 204 +/- 60 pg/ml; p less than 0.06) were significantly lower in group I than in group II. Both at rest and during maximum workload, plasma ANP concentrations were closely related to RAP, PADP, and mean pulmonary artery pressures in both groups. During exercise in all patients, RAP and PADP significantly increased, as well as plasma ANP concentrations. Similar increments in plasma ANP concentrations were accompanied by greater changes in RAP in group II than in group I. However, identical changes in PADP lead to identical increments in plasma ANP concentrations in both groups. In conclusion, the increments of plasma ANP concentrations during physical exercise were independent of the resting values of PADP, RAP, and plasma ANP concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149511     DOI: 10.1007/bf01857647

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  26 in total

1.  Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide during exercise in humans.

Authors:  R C Tsai; T Yamaji; M Ishibashi; F Takaku; S T Hsu; C Y Lai; S J Yeh; J S Hung; D L Wu; Y S Lee
Journal:  J Cardiovasc Pharmacol       Date:  1988-05       Impact factor: 3.105

2.  Effect of acute exercise on plasma immunoreactive-atrial natriuretic factor.

Authors:  H Tanaka; M Shindo; J Gutkowska; A Kinoshita; H Urata; M Ikeda; K Arakawa
Journal:  Life Sci       Date:  1986-11-03       Impact factor: 5.037

3.  Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure.

Authors:  W Rascher; T Tulassay; R E Lang
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

4.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

5.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

6.  Increase in circulating insulin induced by atrial natriuretic peptide in normal humans.

Authors:  D E Uehlinger; P Weidmann; M P Gnädinger; L Hasler; C Bachmann; S Shaw; B Hellmüller; R E Lang
Journal:  J Cardiovasc Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.105

7.  Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy.

Authors:  M Haass; R Dietz; T A Fischer; R E Lang; W Kübler
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

8.  Radioimmunological determination of arginine vasopressin and human atrial natriuretic peptide after simultaneous extraction from plasma.

Authors:  E Hartter; W Woloszczuk
Journal:  J Clin Chem Clin Biochem       Date:  1986-08

9.  The plasma release of atrial natriuretic peptide in man.

Authors:  J V Anderson; J Donckier; W J McKenna; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1986-08       Impact factor: 6.124

10.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.

Authors:  A E Raine; P Erne; E Bürgisser; F B Müller; P Bolli; F Burkart; F R Bühler
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

View more
  1 in total

Review 1.  Exercise for patients with congestive heart failure.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.